Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer

被引：0

作者：

Kotoula, V. ^{[1
]}

Zagouri, F. ^{[1
]}

Alexopoulou, Z. ^{[2
]}

Gogas, H. ^{[1
]}

Lakis, S. ^{[1
]}

Pentheroudakis, G. ^{[1
]}

Bobos, M. ^{[1
]}

Papadopoulou, K. ^{[1
]}

Tsolaki, E. ^{[1
]}

Skondra, M. ^{[1
]}

Karavasilis, V. ^{[1
]}

Koutras, A. ^{[1
]}

Chrisafi, S. ^{[1
]}

Christodoulou, C. ^{[1
]}

Papakostas, P. ^{[1
]}

Linardou, H. ^{[1
]}

Markopoulos, C. ^{[1
]}

Zografos, G. ^{[1
]}

Samantas, E. ^{[1
]}

Fountzilas, G. ^{[1
]}

机构：

[1] Data Off, Hellen Cooperat Oncol Grp, Athens, Greece

[2] Hlth Data Specialists Ltd, Biostat, Athens, Greece

来源：

EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷

关键词：

D O I：

10.1016/S0959-8049(16)30765-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1813

引用

页码：S270 / S270

页数：1

共 50 条

[41] Trastuzumab plus Paclitaxel in HER2-positive Breast Cancer
不详
GYNAKOLOGE, 2016, 49 (08): : 558 - 558
[42] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Verma, Sunil
Miles, David
Gianni, Luca
Krop, Ian E.
Welslau, Manfred
Baselga, Jose
Pegram, Mark
Oh, Do-Youn
Dieras, Veronique
Guardino, Ellie
Fang, Liang
Lu, Michael W.
Olsen, Steven
Blackwell, Kim
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
[43] Trastuzumab therapy in HER2-positive, metastatic breast cancer
Smith, A. D.
Guilbert, K.
Lister, D.
Streilein, S.
Bourrier, V. C.
Lozar, B.
Navaratnam, S.
Harding, G. A.
Pitz, M. W.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[44] Subcutaneous Trastuzumab: A Review in HER2-Positive Breast Cancer
Young-A Heo
Yahiya Y. Syed
Targeted Oncology, 2019, 14 : 749 - 758
[45] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
Lorenz, Judith
GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
[46] The art of prescribing trastuzumab for HER2-positive breast cancer
Outhoff, K.
SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 3 (01) : 16 - 26
[47] PTEN mutations prevalence in HER2-positive breast cancer patients
Elwy, Fatma
El Din, Zeinab Shehab
Assem, Magda M.
Hassan, Nagwa H. A.
Helwa, Reham
REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2023, 36 (01):
[48] Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Zakaria, Nermine H.
Hashad, Doaa
Saied, Marwa H.
Hegazy, Neamat
Elkayal, Alyaa
Tayae, Eman
HUMAN GENOMICS, 2023, 17 (01)
[49] Phase II Trial of Neoadjuvant Pegylated Liposomal Doxorubicin with Paclitaxel and Trastuzumab in Patients with Operable Her2-Positive Breast Cancer
Hyams, D. M.
Leichman, G. C.
Klein, P.
Rietchsel, P.
Levine, E. G.
Gebski, V. J.
Kelley, M. A.
CANCER RESEARCH, 2009, 69 (24) : 570S - 570S
[50] Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Nermine H. Zakaria
Doaa Hashad
Marwa H. Saied
Neamat Hegazy
Alyaa Elkayal
Eman Tayae
Human Genomics, 17

← 1 2 3 4 5 →